India presents a huge opportunity for the diagnostics sector but the lack of minimum standards and weak practices are ...

India’s second-largest pathology laboratory chain, Metropolis Healthcare, posted a 15.5 per cent year-on-year (Y-o-Y) growth ...

Expect demand for early and precise diagnostics to surge due to expansion of telemedicine infrastructure through broadband ...

Metropolis collaborates with Roche Diagnostics India to introduce self-sampling HPV DNA test for early detection of cervical cancer: Our Bureau, Bengaluru Monday, February 3, 2025 ...

Announcements on cancer treatment are important, data shows. Data by Previu Health - a startup working in screening and ...

Metropolis Healthcare rallied 4.83% to Rs 1,819.20 after the company reported 15.4% increase in consolidated net profit to Rs 31.36 crore in Q3 FY25 as against Rs 27.16 crore posted in Q3 FY24.

What was the problem you were grappling with? In 2015, I needed to increase my stake in the company by taking on a significant amount of debt. My biggest concern was how to manage the required cash ...

These efforts will ensure a healthier and more sustainable future for all,” Soi said. Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Ltd. maintained that the diagnostics ...

Ameera Shah, promoter and executive chairperson, Metropolis Healthcare, emphasises the need for key reforms in India's healthcare sector ahead of Budget 2025. For her, the three major areas the ...